Meso Numismatics, Inc. Stock

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Delayed OTC Markets 03:40:26 2024-05-16 pm EDT 5-day change 1st Jan Change
0.036 USD -3.81% Intraday chart for Meso Numismatics, Inc. 0.00% +393.15%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2022 1.53M Sales 2023 2.41M Capitalization 91.2K
Net income 2022 -5M Net income 2023 -9M EV / Sales 2022 8.97 x
Net Debt 2022 13.5M Net Debt 2023 17.12M EV / Sales 2023 7.14 x
P/E ratio 2022
-0.04 x
P/E ratio 2023
-0.01 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 84.19%
More Fundamentals * Assessed data
Dynamic Chart
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc CI
Meso Numismatics, Inc. Announces New Clinics CI
Meso Numismatics, Inc. Reports Sales Results for the Year 2023 CI
Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Meso Numismatics, Inc. announced that it expects to receive $10 million in funding from GHS Investments, LLC CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Meso Numismatics, Inc.'s Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Meso Numismatics, Inc. Expands its Stem Cell Therapy and Regenerative Medicine Centers to Indonesia CI
More news
1 day-3.81%
Current month-25.31%
3 months-25.00%
6 months+350.00%
Current year+393.15%
More quotes
1 week
0.04
Extreme 0.036
0.04
1 month
0.04
Extreme 0.035
0.06
Current year
0.01
Extreme 0.0073
0.06
1 year
0.01
Extreme 0.0072
0.06
3 years
0.01
Extreme 0.0072
0.35
5 years
0.01
Extreme 0.0072
0.35
10 years
0.01
Extreme 0.0072
600.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 19-11-26
Members of the board TitleAgeSince
Chief Executive Officer 59 19-11-26
More insiders
Date Price Change Volume
24-05-16 0.036 -3.81% 9,600
24-05-14 0.0374 -16.65% 1,178
24-05-10 0.0449 +24.72% 23,999

Delayed Quote OTC Markets, May 16, 2024 at 03:40 pm EDT

More quotes
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW